ইস্রায়েল - হিব্রু - Ministry of Health

beit-erez havat milatin ltd - afoxolaner; milbemycin oxime - טבליות לעיסות - afoxolaner 18.75 mg; milbemycin oxime 3.75 mg

ইস্রায়েল - হিব্রু - Ministry of Health

beit-erez havat milatin ltd - afoxolaner; milbemycin oxime - טבליות לעיסות - afoxolaner 37.5 mg; milbemycin oxime 7.5 mg

ইস্রায়েল - হিব্রু - Ministry of Health

beit-erez havat milatin ltd - afoxolaner; milbemycin oxime - טבליות לעיסות - afoxolaner 75 mg; milbemycin oxime 15 mg

ইস্রায়েল - হিব্রু - Ministry of Health

beit-erez havat milatin ltd - afoxolaner; milbemycin oxime - טבליות לעיסות - afoxolaner 9.375 mg; milbemycin oxime 1.875 mg

ইস্রায়েল - হিব্রু - Ministry of Health

a.l. medi-market ltd. - praziquantel; pyrantel embonate - טבליה - praziquantel 20 mg; pyrantel embonate 230 mg

ইস্রায়েল - হিব্রু - Ministry of Health

halperin n.h. medic ltd, israel - lidocaine; prilocaine - קרם - prilocaine 25 mg / 1 g; lidocaine 25 mg / 1 g - prilocaine

ইস্রায়েল - হিব্রু - Ministry of Health

alphamedix ltd, israel - botulinum toxin type a - אבקה להכנת תמיסה לזריקה - botulinum toxin type a 0.8 ng 100 ld50 units / vial - botulinum toxin

ইস্রায়েল - হিব্রু - Ministry of Health

alphamedix ltd, israel - botulinum toxin type a - אבקה להכנת תמיסה לזריקה - botulinum toxin type a 0.2 - 0.4 ng 50 ld50 units / vial - botulinum toxin

ইস্রায়েল - হিব্রু - Ministry of Health

roche pharmaceuticals (israel) ltd - oseltamivir as phosphate - קפסולות - oseltamivir as phosphate 75 mg - oseltamivir - oseltamivir - treatment of uncomplicated acute illness due to influenza infection in adults patients and patients who weigh more than 40 kg who have been symptomatic for no more than 2 days. - post exposure prevention in adults and patients who weight more the 40 kg following contact with a clinically diagnosed influenza case when influenza virus is circulating in the community. - the appropriate use of tamiflu for prevention of influenza should be determined on a case by case basis by the circumstances and the population requiring protection. in exceptional situations (e.g. in case of a mismatch between the circulating and vaccine virus strains and a pandemic situation) seasonal prevention could be considered in adults patients and patients who weigh more than 40 kg.

ইস্রায়েল - হিব্রু - Ministry of Health

roche pharmaceuticals (israel) ltd - oseltamivir as phosphate - קפסולות - oseltamivir as phosphate 75 mg - oseltamivir - oseltamivir - - treatment of uncomplicated acute illness due to influenza infection in adults patients and patients who weigh more than 40 kg who have been symptomatic for no more than 2 days. - post exposure prevention in adults and patients who weight more the 40 kg following contact with a clinically diagnosed influenza case when influenza virus is circulating in the community. - the appropriate use of tamiflu for prevention of influenza should be determined on a case by case basis by the circumstances and the population requiring protection. in exceptional situations (e.g. in case of a mismatch between the circulating and vaccine virus strains and a pandemic situation) seasonal prevention could be considered in adults patients and patients who weigh more than 40 kg.